Tag: COVID
Moderna seeks US-FDA approval for emergency use of BA.4/BA.5 Omicron booster
Subject to the regulatory approval, Moderna is ready to ship bivalent booster mRNA-1273.222 in September
The Gamaleya Center develops Delta & Omicron-adapted Sputnik V vaccine
The Delta and Omicron-adapted version of Sputnik V is the most promising version of the vaccine specifically adapted to new variants as compared to those tailored against the combination of the original strain and Omicron variant
Expo to showcase India’s biotech prowess
A key highlight of the event will be an expo, which will showcase 75 successful startups supported by BIRAC, 75 specialized biotech incubation centres supported by BIRAC, and 50 successful startups supported by Department of Promotion of Industry and Internal Trade
India committed to accessibility of vaccines for all: S&T Minister
India is working actively with the Global Alliance for Vaccines and Immunization (GAVI), WHO, and the Access to COVID-19 Tools (ACT) Accelerator to realize this goal
Study finds Asthma drug can help fight COVID
Indian Institute of Science (IISc) team found that a drug used to treat Asthma and allergies can bind to and block a crucial protein produced by the virus SARS-CoV-2 and reduce viral replication in human immune cells
Potential Covid-19 recurrence in 25% patients: Practo Report
The report ‘Understanding COVID-19: Comparing all three waves in India’ analyses how Indians accessed healthcare during the three covid waves
USFDA declines EUA nod to Covaxin
Despite receiving emergency use listing from the World Health Organization, Covaxin has not been cleared for any age group in the United States
Scientists develop new technology platform to detect SARS-CoV-2
A highlight of the study is that it presents an entirely new strategy to target a unique, unconventional nucleic acid structure specific to the SARS-CoV-2 sequence using small molecules
Scientists develop self-disinfecting, biodegradable face masks to combat COVID-19
The mask exhibits high performance against the COVID 19 virus as well as several other viral and bacterial infections, is biodegradable, highly breathable and washable
Zydus posts consolidated revenues of Rs. 3655 crores in Q3
The company filed 12 additional ANDAs with the USFDA during the quarter and received 9 new product approvals (including 5 tentative approvals) from the USFDA.